Compare Anupam Rasayan with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROCE of 9.75%
- The company has been able to generate a Return on Capital Employed (avg) of 9.75% signifying low profitability per unit of total capital (equity and debt)
Flat results in Mar 26
With ROCE of 8, it has a Very Expensive valuation with a 3.2 Enterprise value to Capital Employed
Stock DNA
Specialty Chemicals
INR 13,768 Cr (Small Cap)
81.00
28
0.00%
0.44
5.10%
4.14
Total Returns (Price + Dividend) 
Latest dividend: 0.7 per share ex-dividend date: Jul-21-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Anupam Rasayan India Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
Anupam Rasayan India Ltd, a specialty chemicals small-cap, has experienced a nuanced shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this, key technical indicators present a mixed picture, with some signalling caution while others suggest potential upside, reflecting the complex market dynamics surrounding the stock as of late July 2026.
Read full news article
Anupam Rasayan India Ltd Downgraded to Sell Amid Technical and Financial Concerns
Anupam Rasayan India Ltd, a specialty chemicals company, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 28 July 2026. This decision follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite a modest share price increase of 0.02% on the day, the company’s overall mojo score has declined to 41.0, reflecting growing concerns about its near-term prospects.
Read full news article
Anupam Rasayan India Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
Anupam Rasayan India Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a mixed picture, with bearish signals on weekly and monthly MACD and RSI, contrasted by mildly bullish daily moving averages and monthly Bollinger Bands. This nuanced technical landscape warrants a closer examination for investors seeking clarity on the stock’s near-term trajectory.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
27-Jul-2026 | Source : BSESubmission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement
Announcement Under Regulation 30 (LODR) - Letter Of Offer
21-Jul-2026 | Source : BSESubmission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders by the Company together with PAC
Announcement under Regulation 30 (LODR)-Newspaper Publication
18-Jul-2026 | Source : BSESubmission of copy of newspaper advertisement clippings pertaining to the Addendum to the Public Announcement Detailed Public Statement and Draft Letter of Offer.
Corporate Actions 
No Upcoming Board Meetings
Anupam Rasayan India Ltd has declared 7% dividend, ex-date: 21 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
21.792
Held by 17 Schemes (0.19%)
Held by 67 FIIs (7.71%)
Kiran Pallavi Investments Llc (31.8%)
Milan R Thakkar (14.41%)
23.23%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 24.07% vs -29.94% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -13.03% vs 10.48% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 122.06% vs -29.59% in Sep 2024
Growth in half year ended Sep 2025 is 280.91% vs -74.03% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 84.34% vs -12.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 161.32% vs -50.07% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 64.61% vs -2.58% in Mar 2025
YoY Growth in year ended Mar 2026 is 82.24% vs -27.41% in Mar 2025






